post-add

Articles for Doctors

PMBJP Achieves Rs 1000 Crore Sales in 2024, Aims To Expand Access To Affordable Medicines

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has reached ₹1000 crore in sales by October 2024, significantly earlier than last year, when this target was met in December. This milestone underscores the increasing public trust in affordable, high-quality medicines provided through the initiative.

Read More
Patient-Centric HMIS: What Is This Technology All About

A patient-centric HMIS is designed with the active involvement of patients, healthcare providers, and administrators in mind. It moves away from traditional systems, which often emphasise data management and compliance, creating solutions that feel disconnected from the user. By prioritizing user experience, healthcare organisations can develop systems that are functional, intuitive, and accessible, ultimately improving the quality of care.

Read More
Niva Bupa And Paras Healthcare Secure SEBI Nod For Upcoming IPOs

Niva Bupa Health Insurance Company and Paras Healthcare have received regulatory approval from the Securities and Exchange Board of India (SEBI) to move forward with their Initial Public Offerings (IPOs). The approvals, granted on October 18, allow both companies to raise capital through a mix of fresh equity and Offer for Sale (OFS) components.

Read More
3rd International And 11th Annual Nursing Conference At RGCIRC Highlights Critical Role Of Nurses In Cancer Care

Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) hosted the 3rd International and 11th Annual Nursing Conference, ‘Nursicon 2024’. The two-day event brought together approximately 400 participants, including renowned international doctors, specialists, nurses, and healthcare professionals, recognising the indispensable role nurses play in cancer care.

Read More
Deepinder Goyal Launches ‘Continue,’ Enters In Health And Wellbeing Space

Deepinder Goyal, the co-founder and CEO of Zomato, has unveiled his latest personal venture, Continue—a startup dedicated to health tracking and mental well-being. Goyal, known for his interest in health optimisation, is now applying that passion to his own entrepreneurial journey.

Read More
Terumo's Vision For Future: An Exclusive Conversation with Hikaru Samejima, CEO Terumo

In a world where technologies in healthcare are rapidly evolving, Japan-based Terumo, aims to push boundaries. As a global player in medical devices and solutions, Terumo’s focus on innovation and patient care has allowed the company to expand its footprint globally, including in India.

Read More
Star Health Insurance Launches Nationwide Campaign on World Osteoporosis Day

In the run-up to World Osteoporosis Day on October 20, Star Health and Allied Insurance, India’s leading standalone health insurer, has launched a nationwide awareness campaign to highlight the dangers of osteoporosis. The campaign is particularly focused on women, who account for 69 per cent of diagnosed osteoporosis cases in India, and aims to promote early diagnosis and preventive care.

Read More
Granules India Receives USFDA Approval For Genetic Formulation To Treat Depression

Granules India has announced that the U S Food & Drug Administration (USFDA) has granted approval for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) in strengths of 100 mg, 150 mg, and 200 mg.

Read More
ICMR Study Predicts Significant Rise In Cancer Cases And Deaths In India By 2045

The study focused on cancer incidence, mortality, and the quality of life for patients, noting that both India and South Africa are likely to experience a significant rise in cancer cases. In India, the increase is particularly pronounced in mouth cancers, with men frequently diagnosed with lip and mouth cancer, while breast cancer remains the most common diagnosis among women.

Read More
NPPA Approves 50 Per cent Hike In Prices of Drugs Used for Asthma, TB, And Glaucoma Treatment

The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Health and Family Welfare, has announced a significant revision in the ceiling prices of essential drugs used to treat conditions such as asthma, tuberculosis (TB), and glaucoma.

Read More

Subscribe to our newsletter to get updates on our latest news